Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
IMV Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
IMV Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
IMV Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
IMV Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
IMV Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IMV Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
IMV Enters into Partnership with Merck 11
PCI Biotech Enters into Agreement with IMV 12
Immunovaccine Enters into Agreement with Incyte 13
Immunovaccine Enters into Agreement with University of Edinburgh 14
Immunovaccine Extends Partnership with UConn Health 15
Immunovaccine Expands Agreement with Leidos 16
Immunovaccine Enters Into Co-Development Agreement With Weill Cornell Medical College For Anti-Cocaine Vaccine 17
ImmunoVaccine Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 18
Equity Offering 19
IMV Plans to Raise up to USD150 Million in Public Offering of Securities 19
Immunovaccine Raises USD11.6 Million in Public Offering of Shares 20
Immunovaccine Raises USD7.4 Million in Public Offering of Shares 21
Immunovaccine Raises USD6 Million in Private Placement of Shares 22
Immunovaccine Raises USD6.2 Million in Private placement of Units 23
Immunovaccine Raises USD8.7 Million in Public Offering of Units 25
Immunovaccine Raise USD1.58 Million in Private Placement of Shares 27
Immunovaccine Withdraws Prospectus For Public Offering Of Shares For US$6.8 Million 28
Immunovaccine Withdraws Private Placement Of Shares For US$1 Million 29
Immunovaccine Completes Private Placement Of Shares For US$4 Million 30
Immunovaccine Completes Private Placement Of Units For US$1.6 Million 31
Immunovaccine Completes Private Placement Of Common Stock For US$2.8 Million 33
IMV Inc – Key Competitors 34
IMV Inc – Key Employees 35
IMV Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Strategy And Business Planning 37
Sep 04, 2018: IMV Celebrates Grand Opening of New Facility in Dartmouth, Nova Scotia 37
Financial Announcements 38
Aug 08, 2018: IMV announces Q2 2018 financial results 38
May 14, 2018: IMV Announces Q1 2018 Financial Results 40
Mar 20, 2018: Immunovaccine Announces Year-End 2017 Financial Results 42
Nov 09, 2017: Immunovaccine Announces Third Quarter 2017 Financial Results 44
Aug 08, 2017: Immunovaccine Announces Financial Results for Quarter Ended June 30, 2017 45
May 10, 2017: Immunovaccine Announces Financial Results for Quarter Ended March 31, 2017 47
Mar 30, 2017: Immunovaccine Announces 2016 Year-End Results 48
Corporate Communications 51
Jun 07, 2018: IMV Appoints Julia P. Gregory to Board of Directors 51
May 31, 2018: Nasdaq Approves Listing of IMV Common Shares 52
Jan 18, 2018: Immunovaccine Appoints Joseph Sullivan as Senior Vice President of Business Development 53
Feb 03, 2017: Immunovaccine Appoints Seasoned Financial Executive Pierre Labbe as CFO 54
Product News 55
Jan 31, 2018: Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology and Enhanced Efficacy in Slowing Tumor Progression 55
Clinical Trials 56
Oct 05, 2017: Immunovaccine Researchers to Present Data at Two Upcoming Conferences that Demonstrate the Broad Applicability of the Companys DepoVax-based Programs 56
Apr 12, 2017: Immunovaccine Announces Positive Year-Long Immunogenicity Data from Phase 1 Clinical Trial for Respiratory Syncytial Virus Vaccine Candidate 57
Other Significant Developments 58
May 10, 2018: IMV – Change of ticker on OTCQX from IMMVF to IMMVD 58
Aug 08, 2017: Immunovaccine Issues Second Quarter 2017 Letter to Shareholders 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60
IMV Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
IMV Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
IMV Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
IMV Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
IMV Inc, Deals By Therapy Area, 2012 to YTD 2018 9
IMV Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IMV Enters into Partnership with Merck 11
PCI Biotech Enters into Agreement with IMV 12
Immunovaccine Enters into Agreement with Incyte 13
Immunovaccine Enters into Agreement with University of Edinburgh 14
Immunovaccine Extends Partnership with UConn Health 15
Immunovaccine Expands Agreement with Leidos 16
Immunovaccine Enters Into Co-Development Agreement With Weill Cornell Medical College For Anti-Cocaine Vaccine 17
ImmunoVaccine Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 18
IMV Plans to Raise up to USD150 Million in Public Offering of Securities 19
Immunovaccine Raises USD11.6 Million in Public Offering of Shares 20
Immunovaccine Raises USD7.4 Million in Public Offering of Shares 21
Immunovaccine Raises USD6 Million in Private Placement of Shares 22
Immunovaccine Raises USD6.2 Million in Private placement of Units 23
Immunovaccine Raises USD8.7 Million in Public Offering of Units 25
Immunovaccine Raise USD1.58 Million in Private Placement of Shares 27
Immunovaccine Withdraws Prospectus For Public Offering Of Shares For US$6.8 Million 28
Immunovaccine Withdraws Private Placement Of Shares For US$1 Million 29
Immunovaccine Completes Private Placement Of Shares For US$4 Million 30
Immunovaccine Completes Private Placement Of Units For US$1.6 Million 31
Immunovaccine Completes Private Placement Of Common Stock For US$2.8 Million 33
IMV Inc, Key Competitors 34
IMV Inc, Key Employees 35
IMV Inc, Other Locations 36
List of Figures
IMV Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IMV Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IMV Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
IMV Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IMV Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
IMV Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
IMV Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
IMV Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9